Skip to content
Review Open access

Associations between a body shape index and cardiometabolic risk markers: age- and sex-specific patterns in a Brazilian population

Oct 2026 · European Heart Journal · 0 citations

Abstract

Visceral adiposity is a major determinant of cardiometabolic risk; however, conventional anthropometric measures such as Body Mass Index may inadequately capture age- and sex-related differences in fat distribution. A Body Shape Index has been proposed as an alternative anthropometric indicator that more accurately reflects abdominal adiposity. Calculated from waist circumference, height, and weight, A Body Shape Index was developed to overcome the limitations of traditional measures by better capturing abdominal fat distribution. This study aims to characterize sex- and age-specific patterns of A Body Shape Index and to assess its independent associations with cardiometabolic risk markers, beyond Body Mass Index, among Brazilian adults. This cross-sectional study included 1,248 adults participating in the Brazilian National Health Survey. Participants were stratified by sex and age groups (<45, 45–59, and ≥60 years). Anthropometric measurements, blood pressure, fasting plasma glucose, and lipid profile were assessed using standardised procedures. Group comparisons were conducted using parametric or non-parametric tests, as appropriate. Multivariable linear and logistic regression analyses were performed to examine associations between A Body Shape Index and cardiometabolic outcomes, adjusting for Body Mass Index and lifestyle-related covariates. A Body Shape Index increased progressively across age groups in both sexes (p <0.001), with a more pronounced increase observed in women after midlife. Among participants aged <45 years, values did not differ between sexes, whereas women aged ≥60 years exhibited higher values than men of the same age (0.085 vs. 0.082, p=0.02). Higher A Body Shape Index was independently associated with increased odds of hypertension (odds ratio 1.38; 95% confidence interval 1.16–1.64) and dyslipidaemia (odds ratio 1.29; 95% confidence interval 1.08–1.54) after adjustment for Body Mass Index. In contrast, Body Mass Index showed stronger associations with hypertriglyceridaemia and low high-density lipoprotein cholesterol. A Body Shape Index was not independently associated with fasting plasma glucose in fully adjusted models. In a nationally representative sample of Brazilian adults, A Body Shape Index captured age- and sex-related differences in body fat distribution that were not reflected by Body Mass Index and was independently associated with blood pressure and lipid abnormalities. These findings indicate that A Body Shape Index may complement traditional anthropometric measures for cardiometabolic risk assessment, particularly in older populations.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.